• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

minami takafumi  南 高文

ORCIDConnect your ORCID iD *help
… Alternative Names

MINAMI Takafumi  南 高文

Less
Researcher Number 70340809
Other IDs
Affiliation (Current) 2025: 近畿大学, 医学部, 准教授
Affiliation (based on the past Project Information) *help 2023 – 2024: 近畿大学, 医学部, 准教授
2013 – 2022: 近畿大学, 医学部, 講師
2007 – 2013: 近畿大学, 医学部, 助教
Review Section/Research Field
Principal Investigator
Urology
Except Principal Investigator
Urology / Basic Section 56030:Urology-related
Keywords
Principal Investigator
ペプチドワクチン / 前立腺癌 / HLA-A3 supertype alleles / HLA-A3 / 癌ワクチン / EZH2 / テーラーメイド / 潜伏感染 / alleles / supertype … More
Except Principal Investigator
… More ペプチドワクチン / 腎細胞癌 / 免疫療法 / EPOR / バイオマーカー / 複合免疫療法 / PDL-1 / HIF-1 / 癌ワクチン療法 / 腎細胞がん / 癌ワクチン / VEGFR / CA9 / HLA-A2 / がんワクチン / HLA-A24 / ワクチン療法 / ペプチド / CA9抗原 / PDL / HIF-1α / ペプチドワクチン療法 / 腎癌 Less
  • Research Projects

    (10 results)
  • Research Products

    (19 results)
  • Co-Researchers

    (9 People)
  •  腎細胞がんに対する癌ワクチンを用いた複合免疫療法の有用性に関する検討

    • Principal Investigator
      植村 天受
    • Project Period (FY)
      2022 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      Kindai University
  •  Development of combination immunotherapy with peptide vaccines for renal cell carcinoma.

    • Principal Investigator
      Uemura Hirotsugu
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      Kindai University
  •  Development of the HLA-A2 restricted multi-peptides vaccine for renal cell carcinoma.

    • Principal Investigator
      UEMURA Hirotsugu
    • Project Period (FY)
      2016 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Urology
    • Research Institution
      Kindai University
  •  Identification of peptides which can be applied to cancer vaccine therapy for patients with prostate cancerPrincipal Investigator

    • Principal Investigator
      MINAMI Takafumi
    • Project Period (FY)
      2015 – 2017
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      Kindai University
  •  Development of multi-peptide tumor vaccine for renal cell carcinoma

    • Principal Investigator
      UEMURA Hirotsugu
    • Project Period (FY)
      2013 – 2015
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Urology
    • Research Institution
      Kinki University
  •  Identification of cancer-derived peptides as potential candidates for the development of anti-cancer vaccines for prostate cancer patientsPrincipal Investigator

    • Principal Investigator
      MINAMI Takafumi
    • Project Period (FY)
      2012 – 2014
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      Kinki University
  •  Development of tailor made peptide vaccines for renal cell carcinoma

    • Principal Investigator
      UEMURA Hirotsugu
    • Project Period (FY)
      2010 – 2012
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Urology
    • Research Institution
      Kinki University
  •  Identification of tumor antigen derived peptides having the potential to promise candidates for cancer vaccine therapy from prostate cancer patients研究代表者南高文(MINAMI TAKAFUMI)Principal Investigator

    • Principal Investigator
      MINAMI Takafumi
    • Project Period (FY)
      2010 – 2011
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Urology
    • Research Institution
      Kinki University
  •  Identification of tumor antigen derived peptides having the potential to promise candidates for cancer vaccine therapy from prostate cancer patientsPrincipal Investigator

    • Principal Investigator
      MINAMI Takafumi
    • Project Period (FY)
      2008 – 2009
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Urology
    • Research Institution
      Kinki University
  •  Development of tailor-madepeptide vaccines for renal eell carcinoma

    • Principal Investigator
      UEMURA Hirotsugu
    • Project Period (FY)
      2007 – 2008
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Urology
    • Research Institution
      Kinki University

All 2021 2017 2016 2015 2014 2013 2012 2008 2007 Other

All Journal Article Presentation Patent

  • [Journal Article] T-cell responses and combined immunotherapy against human carbonic anhydrase 9-expressing mouse renal cell carcinoma2021

    • Author(s)
      Harada Mamoru、Iida Yuichi、Kotani Hitoshi、Minami Takafumi、Komohara Yoshihiro、Eto Masatoshi、Yoshikawa Kazuhiro、Uemura Hirotsugu
    • Journal Title

      Cancer Immunology, Immunotherapy

      Volume: 71 Issue: 2 Pages: 339-352

    • DOI

      10.1007/s00262-021-02992-7

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K16393, KAKENHI-PROJECT-19H03794, KAKENHI-PROJECT-21K07177
  • [Journal Article] Hypoxia-inducing factor (HIF)-1α-derived peptide capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma.2017

    • Author(s)
      1.Minami T, Matsumura N, Sugimoto K, Shimizu N, De Velasco M, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H.
    • Journal Title

      Int Immunopharmacol.

      Volume: 44 Pages: 197-202

    • DOI

      10.1016/j.intimp.2017.01.014

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16H05466, KAKENHI-PROJECT-17K07217
  • [Journal Article] Identification of programmed death ligand 1-derived peptides capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma2015

    • Author(s)
      Minami T., Minami T., Shimizu N., Yamamoto Y., De Velasco MA., Nozawa M., Yoshimura K., Harashima N., Harada M., Uemura H.
    • Journal Title

      Journal of Immunotherapy

      Volume: 38 (7) Issue: 7 Pages: 285-291

    • DOI

      10.1097/cji.0000000000000090

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25430150, KAKENHI-PROJECT-25293336
  • [Journal Article] New polycomb group protein enhancer of zeste homolog (EZH) 2-derived peptide with the potential to induce cancer-reactive cytotoxic T lymphocytes in prostate cancer patients with HLA-A3 supertype alleles.2015

    • Author(s)
      Minami T, Minami T, Shimizu N, Yamamoto Y, De Velasco MA, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H.
    • Journal Title

      Int Immunopharmacol.

      Volume: 26(1) Pages: 133-138

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-15K10612
  • [Journal Article] New polycomb group protein enhancer of zeste homolog (EZH) 2-derived peptide with the potential to induce cancer-reactive cytotoxic T lymphocytes in prostate cancer patients with HLA-A3 supertype alleles2015

    • Author(s)
      Minami T, Minami T, Shimizu N, Yamamoto Y, De Velasco M A, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H.
    • Journal Title

      International Immunopharmacology

      Volume: 26 Issue: 1 Pages: 133-138

    • DOI

      10.1016/j.intimp.2015.03.023

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-24501331, KAKENHI-PROJECT-24592416, KAKENHI-PROJECT-25430150, KAKENHI-PROJECT-25293336
  • [Journal Article] Transfection of poly(I:C) can induce ROS-triggered apoptosis and IFN--mediated growth arrest in human renal cell carcinoma cells via innate adjuvant receptors and the 2-5A system2014

    • Author(s)
      Harashima N, Minami T, Uemura H, Harada M
    • Journal Title

      Molecular Cancer

      Volume: 13 Issue: 1 Pages: 217-217

    • DOI

      10.1186/1476-4598-13-217

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-24501331, KAKENHI-PROJECT-25293336, KAKENHI-PROJECT-25430150
  • [Journal Article] Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24(+) patients with renal cell carcinoma.2014

    • Author(s)
      Minami T, Minami T, Shimizu N, Yamamoto Y, De Velasco M, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H.
    • Journal Title

      Int Immunopharmacol.

      Volume: 20 Pages: 59-65

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25293336
  • [Journal Article] Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma.2014

    • Author(s)
      Minami T, Minami T, Shimizu N, Yamamoto Y, De Velasco M, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H
    • Journal Title

      Int Immunopharmacol.

      Volume: 20 Pages: 59-65

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25293336
  • [Journal Article] Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma.2013

    • Author(s)
      Yoshimura K, Minami T, Nozawa M, Uemura H.
    • Journal Title

      Br J Cancer.

      Volume: 108 Issue: 6 Pages: 1260-1266

    • DOI

      10.1038/bjc.2013.90

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22390305, KAKENHI-PROJECT-25293336
  • [Journal Article] Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma2013

    • Author(s)
      Yoshimura K, Minami T, Nozawa M, Uemura H
    • Journal Title

      Br J Cancer

      Volume: 108(6) Pages: 1260-6

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Journal Article] Phase I/II study of individualized peptide vaccines for HLA-A2/24 positive patients with hormone-refractory prostate cancer2008

    • Author(s)
      Uemura H., Minami T., Tanaka M, 他4名
    • Journal Title

      J. Clin. Oncol. 26

    • Data Source
      KAKENHI-PROJECT-19390419
  • [Journal Article] Idenitification of SART3-derived peptides having the potential to induce cancer patients with HLA-A3 supertype alleles2007

    • Author(s)
      Minami T., Uemura H., Harada M, 他5名
    • Journal Title

      Cancer Immunol.Immunother 56

      Pages: 689-698

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19390419
  • [Patent] HLA-A24分子に結合でき、かつ細胞性免疫に認識されるHIF-1α由来ペプチド、及びそれを含む腎細胞癌ワクチン2016

    • Inventor(s)
      植村天受、南高文
    • Industrial Property Rights Holder
      植村天受、南高文
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2016-209180
    • Filing Date
      2016-10-26
    • Data Source
      KAKENHI-PROJECT-16H05466
  • [Presentation] HLA-A24陽性腎細胞癌症例においてCancer-reactive cytotoxic T lymphocytes を誘導しうるEpoR, PD-L1ペプチドの同定2016

    • Author(s)
      南 高文、南 知子、清水信貴、山本 豊、Marco De Velasco、野澤昌弘、吉村一宏、
    • Organizer
      第104回日本泌尿器科学会総会
    • Place of Presentation
      仙台国際センター、東北大学記念会館、仙台市
    • Year and Date
      2016-04-23
    • Data Source
      KAKENHI-PROJECT-16H05466
  • [Presentation] Clinical role of MHC-class I peptide vaccines for metastatic renal cell carcinoma2013

    • Author(s)
      T Minami, T Minami, N Shimizu, Y Yamamoto, M De Velasco, T Hayashi, M Nozawa, K Yoshimura, T Ishii, H Uemura
    • Organizer
      28th Annual EAU Congress
    • Place of Presentation
      Milan
    • Year and Date
      2013-03-18
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Presentation] HLA-A24 陽性腎細胞癌患者におけるcancer-reactive CTLs を誘導し得るEpoR 抗原由来ペプチドの同定2012

    • Author(s)
      南 高文、南 知子、大関孝之、デベラスコマルコ、清水信貴、山本 豊、辻 秀憲、野澤昌弘、吉村一宏、植村天受
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      札幌市
    • Year and Date
      2012-09-19
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Presentation] 転移性腎がんに対するMHC クラスI ペプチドワクチン療法の役割2012

    • Author(s)
      植村天受、吉村一宏、南 高文、デベラスコ マルコ
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      札幌市
    • Year and Date
      2012-09-19
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Presentation] The Clinical role of peptide vaccines for castration-resistant prostate cancer2012

    • Author(s)
      Takafumi Minami, Takahiro Kimura, Masahiro Nozawa, Kazuhiro Yoshimura, Toru Nakagawa, Akira Yamada, Kyogo Ito, Hiroyuki Fujimoto, Shi Egawa, Hirotsugu Uemura
    • Organizer
      The 10th Annual Meeting of Japanese Society of Medical Oncology
    • Place of Presentation
      Osaka
    • Year and Date
      2012-07-18
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Presentation] HLA-A24陽性腎細胞癌患者におけるcancer-rective CTLsを誘導し得るEpoR抗原由来ペプチドの同定

    • Author(s)
      南 高文、植村天受ほか
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      ロイトン札幌(札幌市)
    • Data Source
      KAKENHI-PROJECT-22390305
  • 1.  UEMURA Hirotsugu (90213397)
    # of Collaborated Projects: 7 results
    # of Collaborated Products: 12 results
  • 2.  DE VELASCO Marco (20449838)
    # of Collaborated Projects: 5 results
    # of Collaborated Products: 7 results
  • 3.  HARADA Mamoru (50260716)
    # of Collaborated Projects: 5 results
    # of Collaborated Products: 5 results
  • 4.  YOSHIMURA Kazuhiro (20283757)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 10 results
  • 5.  TANAKA Motoyoshi (30347562)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 6.  NOZAWA Masahiro (00441080)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 7.  UEJIMA Shigeya (60213336)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 8.  KOTANI Hitoshi
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 9.  原嶋 奈々江
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi